GLP-1-based medications have transformed medical weight management by targeting biological pathways involved in hunger, satiety and food intake.
At Synchronicity Health, GLP-1 weight loss therapy is not treated as a stand-alone injection. Medication is incorporated into a medically supervised plan that considers your health history, body composition, nutrition, muscle preservation and long-term goals.
Somer Schreiber-Small, FNP-C, MSCP, ABAAHP
ABAAHP Diplomate | Certified BHRT Provider | Menopause Society Certified Practitioner | Nearly 30 Years in Clinical Medicine
MSN, Samuel Merritt University • Board-Certified Family Nurse Practitioner
GLP-1, or glucagon-like peptide-1, is a naturally occurring hormone involved in appetite, digestion and blood-sugar regulation.
GLP-1 receptor agonist medications mimic some of the effects of this hormone. They can help reduce hunger, increase feelings of fullness and decrease food intake.
Some weight-loss medications act primarily on GLP-1 receptors.
Others, including tirzepatide, act on both GIP and GLP-1 receptors.
That distinction is why not every medication commonly described as a “GLP-1” works in exactly the same way.
GLP-1-based treatment can influence several processes involved in eating and appetite.
Patients may experience:
These medications are intended to support a broader weight-management strategy rather than replace nutrition, physical activity or medical follow-up.
Two of the best-known medications used in modern weight management are semaglutide and tirzepatide.
Semaglutide is a GLP-1 receptor agonist. FDA-approved for chronic weight management in eligible patients.
Tirzepatide activates both GIP and GLP-1 receptors. The dual agonist is FDA-approved for chronic weight management in eligible adults.
Both medications influence appetite and food intake, but they are not the same medication.
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
|
Medication class |
GLP-1 receptor agonist |
GIP/GLP-1 receptor agonist |
|
Appetite regulation |
Yes |
Yes |
|
Prescription required |
Yes |
Yes |
|
Medical supervision recommended |
Yes |
Yes
|
|
Best choice
|
Depends on the individual
|
Depends on the individual
|
The best medication is not necessarily the medication someone else lost the most weight on.
Your medical history, medications, treatment response, side effects, contraindications and goals all matter.
Prescription weight-management medication may be considered for patients who meet appropriate clinical criteria and have struggled to achieve or maintain sufficient weight loss with lifestyle changes alone.
A clinical evaluation should consider factors such as:
The purpose of the evaluation is to determine whether GLP-1-based therapy is appropriate, not simply to choose a medication from a menu.
GLP-1 medications affect appetite, digestion and other physiological processes.
Effective treatment therefore involves more than receiving medication.
Patients need appropriate screening, dose management, side-effect monitoring, nutrition support and follow-up.
Synchronicity Health also places particular emphasis on a frequently overlooked question:
Are you losing fat, or are you losing muscle too?
Significant weight loss can include loss of lean tissue as well as fat.
That is why protein intake, resistance training and body-composition awareness should be part of a comprehensive medical weight-management program.
Synchronicity Health focuses on helping patients reduce excess body fat while supporting strength and lean mass throughout treatment.
Explore our:
Gastrointestinal symptoms are among the most common side effects of these medications.
Depending on the medication, these may include nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion and reflux.
More serious risks and contraindications also exist, which is why a complete medical evaluation and appropriate monitoring are important.
Your provider should review the risks of the specific medication being considered rather than treating all GLP-1 therapies as interchangeable.
Treatment begins by determining whether medication is appropriate for you.
From there, your plan may include:
Clinical assessment
Medication selection
Dose management
Follow-up visits
Nutrition and protein goals
Body composition monitoring
Muscle-preservation strategies
Adjustments based on response and side effects
Medication history
The goal is not simply to suppress your appetite.
It is to use medication intelligently as part of a broader strategy for improving weight and metabolic health.
GLP-1 receptor agonists mimic endogenous glucagon-like peptide-1, delaying gastric emptying, reducing hunger signals in the hypothalamus, eliminating compulsive food noise, and stimulating glucose-dependent insulin secretion. This dual physiological mechanism keeps food in the stomach longer and prevents postprandial blood sugar spikes, allowing patients to maintain a steady caloric deficit without hunger.
No, Synchronicity Health charges a flat monthly rate—starting at $299 for Semaglutide and $499 for Tirzepatide—regardless of how high your dose is titrated. Unlike many commercial clinics that penalize clinical progress with escalating tier costs, all higher maintenance dosages and injection supplies are fully covered in the baseline monthly membership.
GLP-1 agonists (such as Semaglutide) target only the GLP-1 receptor to suppress appetite, whereas dual GLP-1/GIP agonists (such as Tirzepatide) activate both GLP-1 and glucose-dependent insulinotropic polypeptide receptors. The added GIP activity stimulates adipocyte lipid metabolism and further reduces gastrointestinal nausea, leading to higher average fat loss in comparative clinical trials.
Candidates for GLP-1 therapies generally present with a Body Mass Index (BMI) of 30 or greater, or a BMI of 27 or greater with co-occurring metabolic comorbidities like hypertension, dyslipidemia, or prediabetes. GLP-1 medications are contraindicated in individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Transient gastrointestinal disturbances—including mild nausea, constipation, acid reflux, and early satiety fatigue—are the most common side effects of GLP-1 therapy. These symptoms are minimized through conservative 4-week titration schedules, adequate electrolyte hydration, digestive enzyme support, and temporary anti-emetic medications when necessary.
Monthly GLP-1 memberships at Synchronicity Health include the active prescription medication, insulin syringes, alcohol prep wipes, monthly clinical evaluations, provider messaging, and free dosage titrations. Patients receive comprehensive medical oversight without unexpected pharmacy fees or hidden equipment upcharges.
Yes. Synchronicity Health provides medically supervised weight-management care in Sacramento for appropriate patients, including GLP-1-based treatment options.
You do not need to know whether semaglutide, tirzepatide or another strategy is right for you before scheduling a call.
Schedule a free 15-minute call with Somer to discuss your weight-loss goals, previous treatment and whether Synchronicity may be a good fit.
